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A B S T R A C T   
As long-lived parasites, helminths depend upon immunomodulation of their hosts for survival. The release of 
excretory-secretory (ES) products, including proteins, lipids and RNAs is how successful host manipulation is 
achieved. It has recently been discovered that the ES products of helminths contain extracellular vesicles (EVs), 
with every species investigated found to secrete these lipid-bound structures. EVs are perfect for packaging and 
delivering immune modulators to target cell types. This review outlines the research carried out on helminth EVs 
and their constituents thus far, as well as their interaction with components of the mammalian immune system. 
We discuss how targeting EVs will aid treatment of helminth infection and consider how EVs and their immu-
nomodulatory cargo could be used as therapeutics as we progress through this exciting era.   
1. Introducing helminths 
Parasitic helminths are macroparasites, many of which inhabit the 
digestive tract of their hosts. ‘Helminth’ derives from the Greek for 
‘worm’, with members sharing this similar form. Despite physical sim-
ilarities, the group is made up of anciently-diverged phyla; Nematoda 
(roundworms) and Platyhelminthes (flatworms), the latter subdividing 
into cestodes (tapeworms) and trematodes (flukes). These parasites 
often have complex life cycles, requiring both definitive hosts, in which 
adults reside and sexually reproduce, and intermediate hosts or vectors, 
in which larvae develop and spread. Many parasites also traffic through 
multiple sites in their host, for instance the human hookworms, Necator 
americanus and Ancylostoma duodenale, enter the human body by pene-
trating the skin, then move through the bloodstream to the lung before 
being coughed up, swallowed and reaching their feeding site in the small 
intestine to mature into egg-producing adults (Hotez et al., 2004). In 
terms of interaction with the host, it is therefore important to consider 
the different tissue environments of lifecycle stages. 
Parasitic helminths are almost universal in their colonisation of 
vertebrates, and thus are a health consideration to both humans and 
species of economically important animals. Around 20 % of the world’s 
population are infected by soil-transmitted helminths alone (Pullan 
et al., 2014; Jourdan et al., 2018), with schistosomiasis and the 
vector-borne helminthiases - lymphatic filariasis and onchocerciasis - 
adding another 142 million and 87 million people affected globally by 
helminths (James et al., 2018). Infections are generally long-lived and 
while direct mortalities are few, morbidities are wide ranging, including 
anaemia and growth stunting, cognitive defects, and elephantiasis 
(Pabalan et al., 2018; Pullan et al., 2014). This list increases over time, 
with Onchocerca volvulus, the agent of river blindness, recently being 
implicated as the cause of nodding syndrome, a form of epilepsy in 
children (Johnson et al., 2017). Three helminth infections, the trema-
todes Opisthorchis viverrini and Clonorchis sinensis,andthe blood fluke-
Schistosoma haematobium, have been classified as Group 1 biological 
carcinogens, leading to cholangiocarcinoma (bile duct cancer) and 
squamous cell carcinoma of the bladder (Brindley and Loukas, 2017; 
Iarc, 2012). Infection with helminths can also affect diseases caused by 
other agents; recent areas of investigation include the effect of helminth 
infection on female reproductive health and susceptibility to sexually 
transmitted diseases (Chetty et al., 2020). 
The duration of helminth infections combined with a lack of repli-
cation in their host leads to a reliance on immune evasion for survival, 
with both nematodes and platyhelminths evolving similar strategies 
which can act on all phases of the immune response (Maizels et al., 
2018). Molecules from the worm released into its environment, termed 
excretory secretory (ES) products, form the focus of investigation for 
immunoregulation of the host (Lightowlers and Rickard, 1988; Moreno 
et al., 2021; Maizels et al., 2018; Hotterbeekx et al., 2021), with most 
attention so far on the proteins that can be found within this mixture 
(Harnett, 2014). Further studies into the lipid, glycomic and small 
molecule components of ES products have revealed that these are also 
capable of altering the host immune system (Wangchuk et al., 2019; 
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Hokke and Van Diepen, 2017; Van Die and Cummings, 2010). However, 
a paradigm shift was introduced with the discovery that helminths also 
release extracellular vesicles (Marcilla et al., 2012; Buck et al., 2014), 
and indeed such vesicles have been found in ES products of all helminth 
parasites examined thus far (Tritten and Geary, 2018). These vesicles 
have potential immunomodulatory functions and could provide a 
conduit for helminth parasites to deliver fragile cargo like small RNAs 
through hostile environments, such as the bloodstream or digestive 
system of the host, into host cells where they can act on intracellular 
targets (Coakley et al., 2016) (Fig. 1). In fact, many of the proteins 
identified in ES products may actually be present in or on EVs, with the 
EV proteomes of the intestinal and liver flukes, Echinostoma caproni and 
Fasciola hepatica, accounting for over 50 % of the proteins found in the 
secretome (Marcilla et al., 2012). 
2. Helminth extracellular vesicles 
Extracellular vesicles (EV) are non-replicative lipid-bilayer delimited 
particles released from cells and are classified according to size and 
origin, with subtypes such as exosomes and microvesicles. Exosomes are 
generally 40− 100 nm in size and derive from the endosome via multi-
vesicular bodies (MVB). MVBs fuse with the plasma membrane to release 
the exosomes to the extracellular environment in a process well 
described in mammalian systems, involving the endosomal sorting 
complex required for transport (ESCRT) (Jadli et al., 2020). Though the 
ESCRT forms the principal machinery driving exosome release, 
ESCRT-independent pathways have been reported. These include a 
pathway requiring membrane microdomains formed of the sphingolipid 
ceramide (Trajkovic et al., 2008), and a pathway involving members of 
the tetraspanin protein family, including CD63 (Andreu and Yáñez-Mó, 
2014). Hybrid mechanisms combining these three systems could also 
exist (De La Torre-Escudero et al., 2016). 
Microvesicles, also known as ectosomes or microparticles, are 
derived from budding of the plasma membrane itself and range in size 
from 50− 2000 nm (Sedgwick and D’souza-Schorey, 2018). Apoptotic 
bodies can be much larger, 100− 5000 nm, and ‘bleb’ from the surface of 
cells undergoing apoptosis. Particles that correspond to the size of both 
exosomes and microvesicles have been identified in the ES of helminths 
(Cwiklinski et al., 2015; Hansen et al., 2019), though many seem to be 
exosome-like (Buck et al., 2014; Harischandra et al., 2018). The ESCRT 
machinery required for MVB formation, as well as proteins that partic-
ipate in microvesicle formation, are conserved in helminths including 
species where EV release has not yet been reported (Bennett et al., 
2020b), so helminths certainly seem equipped to make and release EVs 
of either class. Difficulties in differentiating exact cellular origin lead to 
the use of the umbrella term ‘EV’. Interestingly, 55 EV biogenesis pro-
teins were found in EVs released by platyhelminths, whereas only 7 were 
found in those released by nematodes (Bennett et al., 2020b), hinting at 
differences in production between the two groups. 
Not only the cellular source of EVs, but their route of secretion from 
the helminth is still not fully characterised. So far, the main site of dis-
covery has been the gut of the parasite. TEM of the adult intestine of the 
murine model nematode, Heligmosomoides polygyrus identified vesicle 
budding from the epithelial surface, with structures similar in size to 
exosomes at the anterior opening (Buck et al., 2014). Concurrent pro-
teomic analysis identified EV components matching proteins from the 
apical surface of the intestinal epithelium, further supporting this site of 
secretion. miRNA content in EVs from the barber’s pole worm, Hae-
monchus contortus, suggest the gut as the source in L4 larvae but not in 
adults (Gu et al., 2017). Investigation of the miRNA in Ascaris suum, a 
nematode parasite of pigs, did not draw a conclusion about whether EVs 
were released from the anus or secretory pore due to similarities be-
tween EVs from ES products, intestinal tissue and A. suum body fluid 
(Hansen et al., 2019). Staining for EV components suggested the 
excretory-secretory pore of the filarial nematode Brugia malayi as the site 
of vesicle release in microfilariae (Harischandra et al., 2018). Again, 
platyhelminths show differences as EV release is seen directly from their 
tegument, a syncytium covering their bodies used for both protection 
and absorption of nutrients, which in nematodes is replaced by a 
collagenous extracellular cuticle. In the liver fluke F. hepatica, further 
evidence suggests that in addition to exosomes shed from the tegument 
(as indicated by their size and the presence of MVBs), most EVs are 
released through the gut and then oral sucker, with additional output 
from the protonephridial system through the parasite’s excretory pore 
(Bennett et al., 2020a). 
Though source and means of biosynthesis of helminth EVs are 
Fig. 1. Helminth EVs and the epithelium. 
Extracellular vesicles are released by all life 
stages of parasitic helminths, and are taken up 
by the epithelial cells that form the first layer of 
defense against them. EVs downregulate the IL- 
33 receptor subunit ST2 as well as regulators of 
MAP kinase signalling. EVs induce wound 
healing pathways and alter immune regulators 
such as IL-6, resulting in increased epithelial 
repair and compromised anti-helminth defense. 
Images are adapted from Servier Medical Art by 
Servier (http://smart.servier.com/) and modi-
fied by the authors under the following terms: 
Creative Commons Attribution 3.0 Unported 
(CC BY 3.0).   
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important questions to answer, a bigger question to address is what their 
physiological function may be. Is their release incidental to a parasite- 
intrinsic process, or does it fulfil some purpose in host manipulation? 
EVs act across an extraordinary range of biological systems (Kalluri and 
Lebleu, 2020), including mammalian immunity, with increasing evi-
dence that EVs enable immune regulation (Zhou et al., 2020). They form 
a part of the communication between innate and adaptive immune cells; 
activated T-cells transmit DNA-containing exosomes back to presenting 
dendritic cells (DCs), further inducing antiviral responses (Torralba 
et al., 2018). This system can be abused by cancer, leading to immu-
nosuppression (Kugeratski and Kalluri, 2021). Tumour-derived exo-
somes have been found that induce T-regulatory cells (Tregs), reduce 
cytotoxicity of natural killer cells and promote tumour-derived mono-
cyte survival, amongst other things (Bebelman et al., 2018). It is no 
surprise then, that pathogens have also evolved EVs as a means of 
immunosuppression. The malaria parasite, Plasmodium berghei, secretes 
EVs that are able to inhibit T-cell responses (Demarta-Gatsi et al., 2019). 
Leishmania exosomes have been found to push monocytes and dendritic 
cells towards anti-inflammatory phenotypes, increasing Th2 polar-
isation and so disease (Silverman et al., 2010). There is therefore great 
interest in how the EVs identified from parasitic helminths may interact 
with the host immune system, especially as infections are long-lived and 
mainly asymptomatic with widespread evidence for immune 
down-modulation. 
3. EVs – a precious cargo? 
The cargo of EVs includes lipids, nucleic acids and proteins; these 
may be enveloped by the membrane or incorporated within it. Due to 
their size, there is a high ratio of membrane to cytoplasm, so a high 
percentage of ‘contents’ may actually be attached to or form a part of the 
membrane; and unlike a cell all membrane-associated components are 
peripheral as there are no internal membrane-bound structures. Around 
20 % of proteins found within the blood fluke Schistosoma mansoni EVs 
contained transmembrane domains (Kifle et al., 2020b), and 380 surface 
proteins have been identified from F. hepatica EVs (De La Torre-Escudero 
et al., 2019). 
As a result of their biogenesis, there are some components of EVs that 
are shared across kingdoms. In the case of exosomes, ESCRT and 
accessory proteins, required for MVB formation, are found regardless of 
cell type of origin (Colombo et al., 2013). Proteins from the ESCRT 
pathway have been identified in F. hepatica EVs (De La Torre-Escudero 
et al., 2019). Other exosome markers are proteins from the tetraspanin 
family, which require the ESCRT-associated protein ALIX to recruit 
ESCRT-III proteins for their delivery (Larios et al., 2020). Proteins of the 
tetraspanin family form clusters and interact with other proteins to 
organise membrane domains, tetraspanin-enriched microdomains 
(TEMs), and may be the method through which specific proteins can be 
targeted to EV membranes, as well as aiding adherence of EVs to the 
membranes of target cells (Andreu and Yáñez-Mó, 2014). CD9 and CD63 
are endosome-specific tetraspanins that are used as exosome markers in 
mammalian systems (Kowal et al., 2016). Antibodies against human 
CD9 are able to detect tetraspanins in EVs from larvae of the dog tape-
worm Echinococcus granulosus (Nicolao et al., 2019). CD63 homologues 
have been identified as components of F. hepatica and Trichinella spiralis 
EVs (Cwiklinski et al., 2015; Yang et al., 2020) and antibodies against 
the parasite protein increased F. hepatica EV uptake by macrophages (De 
La Torre-Escudero et al., 2019). 
Microvesicles also contain tetraspanins, due to their biogenesis via 
outward budding of the cell membrane, which contains clusters of these 
proteins. Tetraspanins have been found in EVs from the model helminth 
H. polygyrus (Buck et al., 2014) and the blood flukes Schistosoma spp 
(Mekonnen et al., 2020; Samoil et al., 2018) amongst others. As tetra-
spanins appear ubiquitous amongst EVs, they have been tested as po-
tential vaccine antigens, with tetraspanins from the platyhelminths 
E. multilocularis, Opisthorchis viverrini and S. mansoni, inducing protective 
responses of 30–60 % reductions in parasite burdens in mouse models 
(Tran et al., 2006; Dang et al., 2012; Chaiyadet et al., 2019). Among the 
nematodes, mice immunized with tetraspanins from B. malayi generated 
responses able to kill infective larval parasites, although as mice are 
refractory to infection, overall levels of protection could not be evalu-
ated (Dakshinamoorthy et al., 2013). 
As microvesicles bud directly from the plasma membrane, they 
contain many cell-specific membrane proteins which act as clues as to 
the cell type of origin. In H. polygyrus EVs, many proteins were identified 
that are associated with the apical membrane of the intestinal tract in 
the free-living nematode Caenorhabditis elegans, supporting their site of 
release as the gut (Buck et al., 2014). Similarly, some cytoplasmic pro-
teins may indicate provenance, as in the case of a population of extra-
cellular vesicles from F. hepatica which contain the protease cathepsin 
L1, derived from gastrodermal cells of the fluke gut; transmission elec-
tron microscopy (TEM) confirmed this source (Cwiklinski et al., 2015). 
If a function of parasitic helminth EVs is host immune regulation, 
then it would be expected that they contain contents outside of the 
‘ordinary’ EV cargo. Most analyses of helminth EV content have been at 
the protein level. Sotillo et al. performed an analysis of released protein 
datasets and found that while there is no apparent universal EV marker 
for all helminth species, proteins from the EF-hand family were identi-
fied across EVs from cestodes and trematodes, whereas M13 metal-
lopeptidases were present in all nematode EVs (Sotillo et al., 2020). In 
addition, some proteins are present in both EVs and in the soluble 
compartment of ES products, which may explain why both can exert 
parallel immunomodulatory effects; for example, proteins from the 
SCP/TAPS family are common in EVs from several nematode species, 
including the murine models H. polygyrus, Nippostrongylus brasiliensis 
and Trichuris muris (Buck et al., 2014; Eichenberger et al., 2018b, a), as 
well as the sheep parasite Teladorsagia circumcincta (Tzelos et al., 2016). 
This family of proteins, also known as venom allergen-like, are known to 
be secreted by both plant and animal parasitic nematodes to modulate 
host responses (Wilbers et al., 2018). Interestingly, however, the ma-
jority of proteins found in helminth EVs, compared using Pfam acces-
sion, were found in only one parasite species (Sotillo et al., 2020). This is 
perhaps to be expected if EVs are a tool in host interaction, as each 
helminth has a specific host, and niche within that host, in which to 
survive. An unanswered question, however, is whether EV proteins fulfil 
a unique function, or are more effective when delivered as part of the 
vesicle cargo, than when the same proteins are released into the soluble 
milieu. 
Helminth EVs also contain species of small RNAs, which can play a 
role in host-helminth interaction (Sotillo et al., 2020; Wu et al., 2019; 
Fromm et al., 2017). Proteins implicated in RNA-loading into EVs such 
as argonaute 2 (Ago2) are conserved in helminths, though there are 
some differences between phyla (Bennett et al., 2020b). Major vault 
protein (MVP) is conserved solely in platyhelminths and present in their 
EVs, and there has been a lineage-specific expansion of argonaut pro-
teins (WAGOs) in nematodes (Bennett et al., 2020b). A WAGO from 
H. polygyrus is found associated with small interfering (si)RNAs specif-
ically found within EVs, suggesting a means of selective export (Chow 
et al., 2019). It is the micro (mi)RNAs that provide some of the biggest 
clues for immunomodulation, with many found that have homology to 
their host, some against genes involved in immunity (Zamanian et al., 
2015; Buck et al., 2014; Hansen et al., 2019; Zhu et al., 2016; Tritten 
et al., 2016; Yang et al., 2020; Fromm et al., 2015). 
Lipids are also a major group of EV contents, though not as well 
characterised as the protein and small RNA components. They are a vital 
part of the vesicle, forming a membrane to protect and keep together the 
internal cargo. Lipidomic analysis has been undertaken of H. polygyrus 
EVs, which identified enrichment of the ether phospholipids plasmal-
ogens. These are believed to increase rigidity of the membrane, 
enhancing durability in the intestine (Simbari et al., 2016). It is also 
suggested that plasmalogens may protect against reactive oxygen spe-
cies (ROS) or aid fusion with host membranes (Whitehead et al., 2020). 
C. Drurey and R.M. Maizels                                                                                                                                                                                                                  
Molecular Immunology 137 (2021) 124–133
127
Lipids can also be bioactive themselves, contributing to cell uptake and 
modulating immunity directly (Record et al., 2018; Whitehead et al., 
2020). Lipids produced by S. mansoni have been found to trigger M2 
polarisation of macrophages (Assunção et al., 2017) and activate human 
eosinophils (Magalhães et al., 2019), with some suggesting that the most 
effective means of delivery for these lipids is via EV (Coakley et al., 
2019). Further investigation of this group of EV cargo is needed to un-
derstand the multiple roles lipids may play. 
Glycans are another neglected group within helminth EV biology. 
Both EV proteins and lipids can be post-translationally glycosylated, 
which is known to be essential for regulation of protein function (Varki, 
2017). Glycans have been identified as key players in the regulation of 
EV uptake, affecting cell tropism of EVs (Williams et al., 2019). Glycans 
from F. hepatica EVs have been profiled using lectin microarrays, 
showing that their composition is different to that found on the tegu-
ment of the fluke (De La Torre-Escudero et al., 2019; Murphy et al., 
2020). Removal of EV external glycans using glycosidases blocked their 
uptake by a macrophage cell line, suggesting a need for these carbo-
hydrates in cellular uptake (De La Torre-Escudero et al., 2019). Glycans 
may even play a role in biodistribution of helminth EVs; glycosidase 
treatment of mouse liver EVs led to accumulation in the lung, rather 
than the liver (Royo et al., 2019). EV glycans from S. mansoni are similar 
to those found in total schistosomula extracts and include ligands for 
DC-SIGN (CD209), the receptor on dendritic cells needed for EV uptake 
(Kuipers et al., 2020). This suggests that EV glycosylation is needed for 
interaction with host immune cells. Other suggested functions of glycans 
present on the surface of EVs include acting as a shield or source of decoy 
antigens, and activation or evasion of host complement pathways 
(Whitehead et al., 2020). However, more research is needed to elucidate 
the true functions of this group of EV components. Novel proteomic 
approaches will aid in the identification of glycosylation, as well as other 
post-translational modifications such as phosphorylation and ubiquiti-
nation (Montaño et al., 2021). 
4. Not all EVs are equal 
Recently, investigation of different populations of vesicles from in-
dividual helminth species has been undertaken. EVs in ES products are 
not uniform and have been found to differ markedly in terms of size and 
content. EVs can be stratified according to size by centrifuging at 
different speeds, these speeds giving rise to the names of the sub- 
populations. Although a central group of proteins are shared within 
EVs of different sizes, such as some tetraspanins and other proteins 
involved in vesicle biogenesis, binding and trafficking, different protein 
cargoes have been found (Kifle et al., 2020b; Cai et al., 2021; De La 
Torre-Escudero et al., 2019). Smaller EVs from E. granulosus were found 
to be internalised by hepatic cells faster than larger vesicles, and also 
contained more proteins that were recognised by infected human serum, 
suggesting that different populations of EVs have distinct roles in host 
interactions (Cai et al., 2021). Analysis of F. hepatica EV surface proteins 
identified differences between 15k and 120k populations of EV, with 
cathepsin L1 specific for 15k and CD63 enriched in 120k EVs (De La 
Torre-Escudero et al., 2019; Cwiklinski et al., 2015). This correlates to 
differences in cellular origins of the EV sub-populations; with the larger 
15k EVs released from gastrodermal cells lining the gut and 120k EVs 
seen beneath the gastrodermis, seemingly within the liver fluke excre-
tory system (De La Torre-Escudero et al., 2019). Physically ligating both 
the oral sucker and excretory pore of F. hepatica blocked the release of 
the 120k EVs but not the 15k population (Bennett et al., 2020a). A large 
amount of morphological variability is also seen in EVs from F. hepatica 
produced throughout the parasites lifecycle, from eggs, juveniles and 
adults (Sánchez-López et al., 2020). This included vesicles with 
electron-dense ‘spikes’ protruding from their membrane, possibly 
formed of proteins that facilitate membrane fusion, as they do in viruses 
(Harrison, 2015). 
Vesicle contents have also been found to differ depending on gender 
and lifecycle stage of the helminth. The EV proteome of B. malayi is both 
stage and sex specific – more than three times as many proteins were 
identified in female than male EVs (Harischandra et al., 2018). EVs are 
released throughout the B. malayi lifecyle, from microfilariae to adults 
that reside in the lymphatics (Harischandra et al., 2018), however EVs 
are most abundant from L3 larvae, the stage which has to navigate from 
the mosquito, through human skin to the lymphatic system (Zamanian 
et al., 2015). H. contortus adult and L4 EVs are enriched for different 
groups of miRNAs, perhaps reflecting their slightly different niches 
within the abomasum (Gu et al., 2017). The same is true in Dirofilaria 
immitis, where Tritten et al. found that miRNAs are enriched differen-
tially based on both lifecycle stage and sex, though this was from whole 
ES products rather than EVs alone (Tritten et al., 2016). Interestingly, 
the pig nematode A. suum L3 and L4 larval EVs contain more unique 
miRNAs than in the adult (Hansen et al., 2019). This increase of cargo in 
larval stages may be due to the need to manipulate a changing host 
environment during migration, compared to adults which take up fixed 
residence in a specific tissue. 
Nearly all EVs from helminths are collected from parasites cultured 
in vitro and purified from conditioned media; in a rare exception, Zhou 
et al. were able to harvest EVs from the hydatid cyst fluid in E. granulosus 
patients, and compare them with those generated by the protoscolex 
stage of the parasite in vitro (Zhou et al., 2019). Although morpholog-
ically similar, the two sets of EVs were divergent in protein content and 
abundance, with the ex vivo cyst EVs containing over 1000 protein 
species, most of which were absent from the protoscolex vesicles; 
however, the proteins detected in the latter were mostly present in the 
cyst vesicles. Hence, in this study the in vitro collected EVs may not 
represent the full spectrum of components expressed in vivo. 
5. Helminth EVs and immunity 
5.1. EVs and the epithelium 
The first point of contact with the host for most helminths is an 
epithelium of some kind. This is the tissue that alerts the immune system 
to the presence of the worm, through the release of alarmins such as 
TSLP, IL-25 and IL-33 (Oyesola et al., 2020; Peterson and Artis, 2014). 
Intestinal epithelial cell uptake of EVs has been demonstrated with 
vesicles from the nematodes H. polygyrus, N. brasiliensis and T. muris 
(Buck et al., 2014; Eichenberger et al., 2018b, a) and the trematode 
E. caproni (Marcilla et al., 2012). H. polygyrus EV treatment of mouse 
epithelial cell lines led to downregulation of an IL-33 receptor subunit 
(known as ST2) and Dusp1, a regulator of MAPK signalling and key 
component of the anti-inflammatory response (Buck et al., 2014). The 
presence of miRNAs complementary to the 3’ untranslated region of 
Dusp1 in the EVs, and their ability to suppress Dusp1 expression suggests 
a mechanism for this gene regulation (Buck et al., 2014). Interestingly, 
two distinct H. polygyrus ES products are known to interfere with IL-33 
signalling, firstly H. polygyrus Alarmin Release Inhibitor (HpARI) which 
binds IL-33, preventing its release from dying cells (Osbourn et al., 
2017), and a second protein that binds to and inhibits the IL-33 receptor 
ST2, hence its name Binds Alarmin Receptor and Inhibits (HpBARI) 
(Vacca et al., 2020). It is likely that both proteins may be present in EVs 
which, added to downregulation of the receptor itself, identifies IL-33 
signalling as a key target of helminth immunoregulation. 
A special case of helminth-epithelial interaction is in O. viverrini, a 
trematode infecting the bile duct of humans. Parasite EVs are taken up 
by human cholangiocytes, the cells of the bile duct epithelium, pro-
moting their proliferation and inducing wound healing pathways 
(Chaiyadet et al., 2015). The suckers of the worm induce mechanical 
damage of the epithelium, so perhaps by promoting repair mechanisms, 
the parasite has adapted to maintain the health of the host. However, 
relentless cell proliferation induced by O. viverrini ES products alongside 
chronic immunopathology due to the presence of the worm can 
frequently lead to malignant cholangiocarcinoma (Zheng et al., 2017). A 
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parallel may exist with adult schistosomes, which live in the vasculature, 
and so are in contact with the vascular endothelium. Similar to 
O. viverrini, chemokines involved in tissue repair are also upregulated by 
S. mansoni EVs when they are taken up by a human endothelial cell line, 
suggesting a means by which the worm encourages homeostasis in the 
host (Kifle et al., 2020a). Immune regulatory genes, such as IL-6, are also 
differentially regulated, as well as genes involved in blood clotting and 
vasodilation, perhaps aiding this blood-feeding helminth (Kifle et al., 
2020a). 
Helminths that migrate through tissues, such as Schistosomes which 
need to penetrate the skin, are known to release cathepsins and other 
proteases to aid in infiltration (Grote et al., 2018). Cathepsins are even 
found within and on the surface of EVs (De La Torre-Escudero et al., 
2019; Zamanian et al., 2015; Marcilla et al., 2012; Tzelos et al., 2016). 
Arguably, EVs may also contain products that when delivered to cells 
within the epithelium counteract and repair the damage caused by the 
larvae as they pass through. For example, although migration of hook-
worm larvae through the lung causes a large amount of both mechanical 
and enzymatic damage, there is a remarkable amount of rapid repair of 
the pulmonary pathology (Schwartz et al., 2018). EVs may be the means 
through which helminths regulate this. N. brasiliensis EVs suppressed 
inflammatory cytokines IL-6 and IFNγ, as well as upregulating the 
anti-inflammatory cytokine IL-10 in mouse models of colitis (Eichen-
berger et al., 2018a). Reduction of immune signalling will also aid in 
returning the system to homeostasis quickly, keeping the host healthy, 
which is needed if long-lived infections are to be successful. 
In filarial nematodes, microfilariae circulate through the peripheral 
blood of the host, encountering a wide range of host cells. EVs released 
into the blood can be substantial – a single B. malayi microfilaria can 
release around 1.9 × 104 EVs in an hour (Harischandra et al., 2018), 
leading to high levels of EV in the serum. miRNAs from the murine 
filarial model Litomosoides sigmodontis have been found in host serum 
and macrophages, the most abundant of which match those found in EVs 
(Buck et al., 2014; Quintana et al., 2019). Some non-filarial helminths 
also spend some time in the circulation; for example, parasite EVs can be 
isolated from Schistosoma spp. infected human sera, and miRNAs from 
these have been suggested as a tool for diagnosis of schistosomiasis 
(Meningher et al., 2017). Encapsulation of small RNAs in parasite EVs 
would prevent their degradation in the blood, enabling them to be 
delivered across the body and have organism-wide effects. This may be 
particularly important for blood-migrating larval stages to prevent sys-
temic inflammation in response to the invaders. 
5.2. EVs and phagocytes 
The immune cells at the centre of helminth EV studies have been 
phagocytes, specifically macrophages. Macrophage cell lines have been 
shown to take up EVs from B. malayi, H. polygyrus and F. hepatica 
(Coakley et al., 2017; Zamanian et al., 2015; De La Torre-Escudero et al., 
2019). EVs from the zoonotic marine nematode Anisakis spp are taken up 
by a human monocyte cell line (Boysen et al., 2020). Though perhaps it 
is to be expected that phagocytic cells will constitutively internalise EVs 
from the environment around them, it has been shown that uptake 
differs from classical endocytosis induced by antibodies. Antibodies 
against S. mansoni tetraspanins actually block uptake of both exosome- 
and microvesicle-like EVs into a human monocyte cell line (Kifle et al., 
2020a). Coakley et al. found murine macrophages took up EVs from 
H. polygyrus via phagocytosis or endocytosis into distinct foci in the 
cytoplasm suggesting an endosomal location, leading to inhibition of 
both type 1 (M1) and type 2 (M2) macrophage activation (Coakley et al., 
2017). Significantly, when antibodies against the EVs were added, up-
take was enhanced but EVs were redirected into lysosomes, and sup-
pression of macrophage function was no longer seen (Coakley et al., 
2017). Hence the mode of uptake critically determines the intracellular 
fate of the vesicles. In macrophages, H. polygyrus EVs suppressed 
expression of the IL-33 receptor subunit ST2, echoing earlier findings 
that the same EVs were able to suppress ST2 expression in innate 
lymphoid cells (ILCs) in vivo (Buck et al., 2014). Blocking the IL-33 
receptor effectively leaves cells blind to the damage caused by 
migrating and feeding helminths, preventing activation of immune cells. 
Alteration of phagocyte activation is a widespread feature of hel-
minth EVs. RAW264.7 macrophages become skewed towards an M1-like 
phenotype when cultured with EVs from adult S. japonicum (Wang et al., 
2015). EVs from B. malayi infective L3 larvae also induce an M1 
phenotype when they are taken up by a murine macrophage cell line 
(Zamanian et al., 2015). This is in contrast to live Brugia and ES prod-
ucts, which stimulate an M2 phenotype in macrophages (Sharma et al., 
2018; Semnani et al., 2011). EVs are therefore a discrete portion of 
helminth secreted products, with demonstrably separate actions to other 
constituents of the milieu. Moreover, the encasement within a lipid 
membrane may allow delivery of cargo to specific cells such as leuko-
cytes, in contrast to products that are directly secreted. 
EVs from the microfilariae of B. malayi are internalised by both 
human monocytes and dendritic cells (DCs), where they downregulate 
the signalling pathway of mammalian Target Of Rapamycin (mTOR) 
(Narasimhan et al., 2016; Ricciardi et al., 2021). This is achieved via the 
presence of miRNAs that target the mTOR pathway (Ricciardi et al., 
2021). The mTOR pathway is a central regulator in the effector response 
of innate immune cells, and targeting this pathway affects polarisation, 
migration, cytokine response and antigen presentation in one (Weich-
hart et al., 2015). E. granulosus EVs are also taken up by DCs, inducing 
their maturation and an unconventional activation profile, with an in-
crease in CD86, required for costimulation of T-cells, but a decrease in 
MHCII, needed for antigen presentation (Nicolao et al., 2019). Similar 
results were shown using F. hepatica EVs to stimulate DCs, with 
increased costimulatory markers, including CD86, but lacking the acti-
vation marker ICAM-1 needed for long lasting T-cell interaction (Mur-
phy et al., 2020). DCs exposed to F. hepatica EVs went on to inhibit 
antigen-specific production of the T-cell growth factor IL-2 by T-cells, 
and did not activate the Th2 responses normally seen in response to 
F. hepatica infection (Murphy et al., 2020). Targeting antigen presenting 
cells such as DCs in this way aids the parasite in blocking antigenic 
presentation and prevents activation of the next arm of the immune 
system, adaptive immunity (Fig. 2). 
5.3. Helminth EVs and adaptive lymphocytes 
Though helminth EVs can influence adaptive immunity via regula-
tion of antigen presenting cells, there is also evidence that EVs are able 
to manipulate lymphocytes directly. Murine peripheral blood mono-
nuclear cells (PBMCs) cultured with EVs from E. granulosus showed in-
hibition of CD4+ and CD8+ T cell proliferation, as well as release of 
inflammatory cytokines, and of IL-10 (Zhou et al., 2019). On the other 
hand, culture of T. spiralis EVs with human PBMCs induced IL-6 and 
IL-10 release (Kosanović et al., 2019). Although tested on different host 
cells, it is clear that EVs from different helminth species can have 
different actions and opposing targets. In the case of T. spiralis, the ef-
fects of EVs would promote parasite survival: IL-10 is an 
anti-inflammatory regulatory cytokine, able to enhance the Th2 
response but also increase T-regulatory cell (Treg) expansion so differing 
regulation of this cytokine may be needed dependent on life stage and 
location in the host. IL-6 is known to limit the Th2 response in helminth 
infection (Smith and Maizels, 2014), perhaps via expansion of Tregs 
with enhanced suppressive capacity (Hagenstein et al., 2019). 
Manipulation of the host immune response via Tregs could be a 
general target for EVs. Treg expansion would amplify anti-inflammatory 
signals more broadly than targeting effector T cells directly, and would 
allow protection of the host from potentially pathogenic immune re-
sponses as well as enabling the parasite to survive for longer (White 
et al., 2020). Accordingly, EVs from T. spiralis were able to expand Tregs 
in a colitis model in vivo (Yang et al., 2020). Moreover, H. polygyrus EVs 
contain a Transforming growth factor (TGF)-β mimic (TGM) protein 
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(Buck et al., 2014), which induces naive peripheral T cells to convert to 
suppressive Foxp3+ Tregs (Johnston et al., 2017). Other EV cargoes 
include proteins known to modulate T cells, for instance EVs of 
E. granulosus larvae contain basigin, also known as CD147, which reg-
ulates lymphocyte responsiveness, inhibiting T-cell proliferation (Nic-
olao et al., 2019). 
The central feature of adaptive immunity is specific recognition of 
pathogen antigens through B cell and T cell receptors against defined 
epitopes. However, identification of potential epitopes that the adaptive 
immune system can target is still at a very early stage. On the one hand, 
membrane-bound proteins exposed on the EV surface area could present 
many opportunities for recognition. Antibodies against the surface lead 
to prevention of uptake, or uptake into degradative pathways, rendering 
their immunosuppression null (Coakley et al., 2017; Chaiyadet et al., 
2019). Studies have found vaccination with EVs has provided some 
protective immunity against challenge with helminth parasites 
(Chaiyadet et al., 2019; Coakley et al., 2017; Trelis et al., 2016; Shears 
et al., 2018). Antibodies against the tetraspanins found on EV surfaces 
are also able to provide protection against S. mansoni in mice (Mekonnen 
et al., 2020). In fact, tetraspanins from E. multilocularis, B. malayi and 
O. viverrini have been considered as vaccine targets (Dakshinamoorthy 
et al., 2013; Dang et al., 2012; Phung et al., 2019), though in the case of 
platyhelminth parasites tetraspanins are also found on the tegumental 
surfaces, so the target of immunity may not be the EVs. 
On the other hand, the levels of immunity induced by EVs vary. No 
decrease in worm burden was seen after vaccination without adjuvant 
for the trematode E. caproni, despite reduction in eggs (Trelis et al., 
2016), compared to 80 % reduction in worm burden in the case of 
H. polygyrus vaccination with alum as an adjuvant (Coakley et al., 2017). 
The nature of EVs means that proteins that may be immunogenic are 
protected inside the lipid membrane, preventing uptake by antigen 
presenting cells. In infections, the host may therefore not naturally 
generate antibodies against EV components; the need for adjuvants in 
successful vaccinations supports this. However, antigens used for 
immunodiagnosis of echinococcosis and cysticercosis were found among 
proteins identified in EVs from the cestodes E. multilocularis and Taenia 
crassiceps, suggesting that at least some proteins are processed and 
presented to the adaptive immune system in these infections (Ancarola 
et al., 2017). IgA and IgG in sera from T. circumcincta-infected sheep 
bound to components of EV-enriched ES products also suggesting the 
presence of some antigens (Tzelos et al., 2016). 
There is also a history of EV proteins having been selected as vaccine 
antigens by other criteria. Alongside the tetraspanins, ectoenzymes such 
as H11 and metalloproteases (MEPs) are also found in EVs (Tzelos et al., 
2016; Buck et al., 2014). These were developed as vaccine candidates 
against H. contortus many years before EVs were discovered in this 
parasite (Andrews et al., 1995), on the premise that they were “hidden 
antigens” located on the worm intestinal epithelium, that would be 
neutralised by antibodies ingested with the parasite’s blood meal (Nis-
bet et al., 2016). While this may well be the mode of action, it is now 
possible that vaccine-elicited antibodies block the function of EVs 
which, derived from the worm intestine, express the same antigens on 
their membranes. Currently, the H. contortus vaccine is known 
commercially as “Barbervax”, and is in use on livestock (Smith, 2014). 
Although this vaccine does confer protection against H. contortus 
infection, it is short-lived due to a failure to elicit long-term memory 
responses, indicating either that worm gut proteases are not accessed 
and presented to induce a memory response, or that EVs are intrinsically 
poorly immunogenic or evade antigen presentation in other ways. 
Tetraspanins and proteases are found in EVs across many different 
species of helminth, suggesting that vaccines utilising them as antigens 
could potentially be pan-specific. This would be useful for human hel-
minth infections, as areas endemic for diseases like human hookworm 
and schistosomiasis overlap, with coinfection common (Hotez et al., 
2008). Targeting a functionally constrained and conserved antigen 
required for vesicle biogenesis would also prevent the evolution of 
resistance, as well as preventing EVs manifesting the immunomodula-
tion described above (Drurey et al., 2020). 
5.4. Targeting EVs for chemotherapy of helminth infection 
In addition to using components of helminth EVs as vaccine targets, 
Fig. 2. Helminth EVs and myeloid cells. 
Helminth extracellular vesicles are taken up by 
myeloid cells, interfering with innate defense 
pathways. (1) EVs from H. polygyrus are able to 
downregulate the IL-33 receptor subunit ST2, 
reducing their ability to respond to this cyto-
kine. (2) EVs from B. malayi contain miRNAs 
that target components of the mTOR signalling 
pathway, downregulating it. These effects, as 
well as others yet characterised, combine to 
alter the activation state of macrophages. (3) 
EVs from S. japonicum and B. malayi induce M1 
polarisation, whereas H. polygyrus EVs inhibit 
both M1 and M2 polarisation. (4) Helminth EVs 
interfere with the expression of components 
involved in antigen presentation and lympho-
cyte activation. E. granulosus EVs cause a 
decrease in MHC II in dendritic cells. 
E. granulosus and F. hepatica EVs both increase 
the costimulatory marker CD86 in dendritic 
cells. (5) Antibodies raised against helminth EVs 
prevent their action, either by preventing up-
take altogether, or leading to their uptake into a 
degradative pathway in the lysosome. 
Images are adapted from Servier Medical Art by 
Servier (http://smart.servier.com/) and modi-
fied by the authors under the following terms: 
Creative Commons Attribution 3.0 Unported 
(CC BY 3.0).   
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they may also be targeted directly to prevent their immunomodulatory 
functions. Drugs can be used to target their specific means of biogenesis. 
Bennett et al. used the chemical inhibitor of neutral sphingomyelinases 
GW4869 to successfully repress the release of 120 K EVs from F. hepatica 
in vitro (Bennett et al., 2020a). Sphingomyelinases are needed to convert 
sphingomyelin to ceramide, which drives ESCRT-independent EV 
biogenesis via membrane curvature (Verderio et al., 2018). Use of 
GW4869 also altered the tissues of the liver fluke, with a highly vacu-
olated tegumental syncytium and parenchymal tissue, suggested to be 
due to the accumulation of sphingomyelin in the cells (Bennett et al., 
2020a). Treatment with the inhibitor was non-lethal in vitro, but it re-
mains to be seen whether this inhibition of EV release would be able to 
reduce parasite survival in vivo. 
Ivermectin, a drug already used widely to treat helminth infections in 
both humans and animals, has been found to inhibit EV release in 
B. malayi, D. immitis and A. suum (Harischandra et al., 2018; Loghry 
et al., 2020). Other anti-helminth drugs, including albendazole and le-
vamisole, do not show inhibition of EV secretion, and no effect of iver-
mectin was seen on a D. immitis strain that has resistance to the drug, 
suggesting a specific mode of action for ivermectin (Loghry et al., 2020; 
Harischandra et al., 2018). Ivermectin is suggested to work via activa-
tion of glutamate-gated chloride channels, leading to hyperpolarisation 
of cell membranes and so paralysis, however ivermectin can also affect 
other pathways and its mechanism of action is not fully understood 
(Laing et al., 2017). Effects on EV secretion by ivermectin are seen at far 
lower concentrations than that needed for motility effects, and closer to 
the concentrations found after treatment in vivo (Loghry et al., 2020). 
This suggests that a therapeutic mode of action of ivermectin could 
involve inhibition of helminth EV secretion, preventing immunomodu-
lation of the host. 
5.5. Helminth EVs in vivo – anti-inflammatory therapeutic potential? 
A major theme in helminth research is the possibility that helminth 
products or their derivatives could successfully treat inflammatory dis-
orders such as asthma or colitis (Ryan et al., 2020; Maizels et al., 2018). 
Hence, the observed immunomodulation by helminth EVs with a 
negative impact in the context of infection, may be transformed into 
useful therapeutic agents. Indeed, helminth EVs applied to models of 
inflammation have already been shown to alleviate symptoms, with the 
most common models used being DSS- or TNBS-induced colitis, as a 
model of inflammatory bowel disease (IBD). F. hepatica EVs are able to 
prevent DSS-induced colitis, reducing both clinical symptoms and his-
tological alterations (Roig et al., 2018). A decreased level of the 
pro-inflammatory cytokines IL-6 and TNF was measured, but no changes 
in IL-10 levels were seen, which along with protection being maintained 
in Rag1− /− mice, lacking B and T cells, suggests no role for Tregs (Roig 
et al., 2018). The most likely agents of protection were suggested to be 
macrophages, due to the characterised effects of helminth infections 
activating them to an anti-inflammatory M2 type. 
Investigations with T. spiralis EVs have, however, revealed roles for 
both macrophages and Tregs. Treatment of mice with T. spiralis EVs 
reduces the severity of both DSS- and TNBS-induced colitis (Yang et al., 
2020; Gao et al., 2021). Lower levels of the pro-inflammatory cytokines 
IL-1β and TNF were measured in colonic tissue, alongside an increase in 
the anti-inflammatory Th2 cytokines IL-4 and IL-13. In contrast with the 
F. hepatica study, levels of IL-10 were also increased, agreeing with re-
sults found from EV treatment of cells in vitro (Kosanović et al., 2019). 
Increased expression of Foxp3 was found in colonic tissue, with an in-
crease in Foxp3+ Tregs in the MLN, suggesting a role for Tregs in 
reduction of TNBS-induced colitis (Yang et al., 2020). In the DSS model, 
EVs were found to inhibit M1 macrophage polarisation, with an 
increased infiltration of M2 macrophages into the colon believed to be 
responsible for tissue repair, lower clinical activity and histopatholog-
ical scores (Gao et al., 2021). In support of this, macrophages alone, 
transferred after activation to M2 by T. spiralis, are enough to inhibit 
DSS-induced colitis (Kang et al., 2019). 
Both these T. spiralis studies used injection with PBS alone as a 
control to EV treatment in intraperitoneal injections, so it cannot be 
ruled out that EVs could be acting via antigenic diversion rather than 
actively reducing inflammation via immunomodulation. However, EVs 
from the model hookworm N. brasiliensis but not the whipworm T. muris 
were able to protect against TNBS- induced colitis in mice, suggesting 
specificity (Eichenberger et al., 2018a). Treatment with N. brasiliensis 
EVs led to a reduction in levels of pro-inflammatory cytokines, including 
IL-1β and IL-6, alongside increased IL-10 levels, which were higher than 
that seen for whole ES product treatment (Eichenberger et al., 2018a). 
Differences in miRNA content between EVs from the two species were 
suggested to be the reason behind the effectiveness of N. brasiliensis EVs, 
with more cytokine-encoding genes predicted to be targeted by this 
species (Eichenberger et al., 2018a). 
There is also evidence that helminth EVs reduce inflammation in 
non-intestinal tissues. H. polygyrus EVs reduce inflammation in the 
Alternaria lung allergy model, which induces IL-33 release leading to 
lung eosinophilia. EV treatment led to a reduction in eosinophils and 
suppressed IL-5 and IL-13 expression in ILCs (Buck et al., 2014). 
Expression of the IL-33 receptor ST-2 was reduced in these cells, which is 
also found in macrophages exposed to these EVs (Coakley et al., 2017). 
H. polygyrus is a model for soil-transmitted helminths and does not 
migrate through the murine lung. The ability of EVs from this species to 
reduce inflammation in a tissue distal to its host niche suggests that 
helminth EVs have the potential for use as anti-inflammatory thera-
peutic agents throughout the body. 
Medicine could also learn from the packaging of the EV itself, as a 
way of content delivery to specific cell types. Overexpression of the EV 
marker CD63 fused to OVA encouraged its packaging into EVs which 
were able to induce higher immune responses against OVA (Kanuma 
et al., 2017). Artificial spherical vesicles known as liposomes have 
already shown promise as oral vaccines in the N. brasiliensis mouse 
model (Bartlett et al., 2020), and adding components found in EVs could 
make them more immunogenic. It is an interesting thought that the very 
weapons helminths use to control their hosts could be turned against 
them and used for their downfall. Conversely, rather than using EVs to 
induce stronger immunity, by including immunomodulatory proteins 
from helminths as the cargo, they could be used as targeted 
anti-inflammatories (Mardahl et al., 2019). Further research is needed 
on both components involved in vesicle targeting and exact means of 
immunomodulation, but this is an exciting possibility. 
6. Concluding remarks 
Dependent on their hosts for survival, helminths are uniquely placed 
for the evolution of products with immunomodulatory properties. 
Extracellular vesicles contained within helminth excretory/secretory 
products are one of the strategies used by the parasite to manipulate 
multiple layers of the immune system. We are only just beginning to 
understand the functions of the varied proteins, lipids, carbohydrates 
and RNAs packaged within EVs and their effects on the host. Future 
research is needed to characterise the specific actions of EV cargo on 
cells of the immune system. Not only are these findings fascinating from 
a host-parasite interaction perspective, but they may also inform ther-
apeutic strategies for both helminth infection and inflammatory disease. 
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